Two people who received Pfizer's respiratory syncytial virus (RSV) vaccine during a clinical trial were later diagnosed with Guillain-Barre syndrome, and the US Food and Drug Administration has asked Pfizer to conduct a safety study if the shot is approved, according to agency documents released Friday.
#people #responsible #recommendations #disease-control #pfizer-vaccine #hospitalizations #immune-system #older-adults #severe-illness
[
add
]
[
|
|
...
]